• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮下植入式心律转复除颤器植入与导管消融:致心律失常性右室心肌病室性心动过速管理的分步计划方法

Subcutaneous ICD Implantation and Catheter Ablation: A Step-Planned Approach for Ventricular Tachycardia Management in ARVC.

作者信息

Sanniti Aurora, Zagari Domenico, Renzullo Elvira, Valeriano Chiara, Moretti Paolo, Spadacini Giammario, Tritto Massimo

机构信息

Electrophysiology and Pacing Unit, Humanitas Mater Domini Clinical Institute, Castellanza, Italy.

Department of Biomedical Sciences, Humanitas University-Pieve Emanuele, Milan, Italy.

出版信息

JACC Case Rep. 2022 Feb 16;4(4):185-191. doi: 10.1016/j.jaccas.2021.12.007.

DOI:10.1016/j.jaccas.2021.12.007
PMID:35199014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8855132/
Abstract

Secondary prevention of sudden cardiac death in the young patient with arrhythmogenic right ventricular cardiomyopathy and hemodynamically tolerated ventricular tachycardia is still a challenging field. We present a combined approach, including subcutaneous implantable cardioverter-defibrillator (ICD) and catheter ablation, as a promising treatment to prevent both ventricular tachycardia recurrences and ICD shocks. ().

摘要

对于患有致心律失常性右心室心肌病且血流动力学耐受室性心动过速的年轻患者,心脏性猝死的二级预防仍是一个具有挑战性的领域。我们提出一种联合治疗方法,包括皮下植入式心律转复除颤器(ICD)和导管消融,作为预防室性心动过速复发和ICD电击的一种有前景的治疗方法。()

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58f/8855132/24eedb4daafa/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58f/8855132/2fd725ec8cc8/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58f/8855132/73fc0fbd2f2d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58f/8855132/1fe81d8f21d4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58f/8855132/2ad0d8299c96/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58f/8855132/b550ba6dbf47/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58f/8855132/24eedb4daafa/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58f/8855132/2fd725ec8cc8/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58f/8855132/73fc0fbd2f2d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58f/8855132/1fe81d8f21d4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58f/8855132/2ad0d8299c96/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58f/8855132/b550ba6dbf47/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58f/8855132/24eedb4daafa/gr5.jpg

相似文献

1
Subcutaneous ICD Implantation and Catheter Ablation: A Step-Planned Approach for Ventricular Tachycardia Management in ARVC.皮下植入式心律转复除颤器植入与导管消融:致心律失常性右室心肌病室性心动过速管理的分步计划方法
JACC Case Rep. 2022 Feb 16;4(4):185-191. doi: 10.1016/j.jaccas.2021.12.007.
2
Appropriate and Inappropriate Implantable Cardioverter Defibrillators Therapies in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Patients.致心律失常性右室心肌病/发育不良患者中合适与不合适的植入式心律转复除颤器治疗
Cardiol Res. 2018 Aug;9(4):204-214. doi: 10.14740/cr734w. Epub 2018 Aug 10.
3
Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.择期心律失常性右室心肌病患者行导管消融术治疗室性心动过速且不植入埋藏式心脏复律除颤器的临床疗效。
Europace. 2021 Sep 8;23(9):1428-1436. doi: 10.1093/europace/euab172.
4
Ventricular Flutter and Pleomorphic Ventricular Tachycardia-Induced Syncope in Borderline Arrhythmogenic Right Ventricular Cardiomyopathy.边缘性致心律失常性右室心肌病中的室性扑动和多形性室性心动过速所致晕厥
JACC Case Rep. 2022 Sep 7;4(17):1134-1139. doi: 10.1016/j.jaccas.2022.07.027.
5
Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?致心律失常性右室心肌病。抗心律失常药物、导管消融术还是植入式心律转复除颤器?
Herz. 2005 Mar;30(2):91-101. doi: 10.1007/s00059-005-2677-6.
6
Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry.心律失常性右室心肌病患者在未接受背景植入式心脏复律除颤器治疗的情况下接受导管消融的疗效:一项多中心国际室性心动过速注册研究。
JACC Clin Electrophysiol. 2019 Jan;5(1):55-65. doi: 10.1016/j.jacep.2018.09.019. Epub 2018 Nov 28.
7
Impact of substrate-based ablation for ventricular tachycardia in patients with frequent appropriate implantable cardioverter-defibrillator therapy and dilated cardiomyopathy: Long-term experience with high-density mapping.基于基质的消融对频发恰当的植入型心律转复除颤器治疗和扩张型心肌病患者室性心动过速的影响:高密度标测的长期经验。
Rev Port Cardiol (Engl Ed). 2021 Nov;40(11):865-873. doi: 10.1016/j.repce.2021.11.006.
8
Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).致心律失常性右室心肌病(ARVC)的射频消融治疗
Curr Cardiol Rep. 2017 Sep;19(9):82. doi: 10.1007/s11886-017-0893-3.
9
Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.植入型心律转复除颤器在伴心脏传导障碍的核纤层蛋白 A/C 突变携带者中的应用。
Heart Rhythm. 2013 Oct;10(10):1492-8. doi: 10.1016/j.hrthm.2013.06.020. Epub 2013 Jun 26.
10
Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience.皮下植入式心律转复除颤器在致心律失常性右室心肌病/发育不良患者中的应用:一项跨大西洋经验。
J Am Heart Assoc. 2018 Nov 6;7(21):e008782. doi: 10.1161/JAHA.118.008782.

本文引用的文献

1
Epicardial access complications during electrophysiology procedures.心外膜入路在电生理检查过程中的并发症。
J Cardiovasc Electrophysiol. 2021 Jul;32(7):1985-1994. doi: 10.1111/jce.15101. Epub 2021 May 20.
2
Subcutaneous or Transvenous Defibrillator Therapy.皮下或经静脉除颤器治疗。
N Engl J Med. 2020 Aug 6;383(6):526-536. doi: 10.1056/NEJMoa1915932.
3
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.2019 HRS 专家共识声明:心律失常性心肌病的评估、风险分层和管理。
Heart Rhythm. 2019 Nov;16(11):e301-e372. doi: 10.1016/j.hrthm.2019.05.007. Epub 2019 May 9.
4
Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience.皮下植入式心律转复除颤器在致心律失常性右室心肌病/发育不良患者中的应用:一项跨大西洋经验。
J Am Heart Assoc. 2018 Nov 6;7(21):e008782. doi: 10.1161/JAHA.118.008782.
5
Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.致心律失常性右室心肌病患者室性心动过速导管消融的长期预后
Circ Arrhythm Electrophysiol. 2015 Dec;8(6):1413-21. doi: 10.1161/CIRCEP.115.003562. Epub 2015 Nov 6.
6
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.心肌炎的病因、诊断、治疗和治疗的现有知识状况:欧洲心脏病学会心肌和心包疾病工作组的立场声明。
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d. doi: 10.1093/eurheartj/eht210. Epub 2013 Jul 3.
7
Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.致心律失常性右室心肌病/发育不良患者的植入式心脏转复除颤器:患者结局、恰当和不恰当干预的发生率及并发症。
Circ Arrhythm Electrophysiol. 2013 Jun;6(3):562-8. doi: 10.1161/CIRCEP.113.000392. Epub 2013 May 14.
8
Imaging of scar in patients with ventricular arrhythmias of right ventricular origin: cardiac magnetic resonance versus electroanatomic mapping.右心室起源室性心律失常患者瘢痕的影像学:心脏磁共振与电解剖标测比较。
J Cardiovasc Electrophysiol. 2011 Dec;22(12):1359-66. doi: 10.1111/j.1540-8167.2011.02127.x. Epub 2011 Jul 7.
9
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.致心律失常性右室心肌病/发育不良的诊断:工作组标准的拟议修改。
Eur Heart J. 2010 Apr;31(7):806-14. doi: 10.1093/eurheartj/ehq025. Epub 2010 Feb 19.
10
Prognostic importance of defibrillator shocks in patients with heart failure.除颤电击对心力衰竭患者的预后重要性。
N Engl J Med. 2008 Sep 4;359(10):1009-17. doi: 10.1056/NEJMoa071098.